Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimecheck M 0.5 Tablet SR

Prescription Icon
Prescription Required

Marketer

Prevego Healthcare & Research Private Limited

Salt Composition

Glimepiride (0.5mg) + Metformin (500mg)

Overview Glimecheck M 0.5 Tablet SR

Diabetic patients using Glimecheck M 0.5 SR tablets, a dual-action antidiabetic medication, should adhere to prescribed dosage and timing for optimal blood glucose management. This medication, effective in controlling type 2 diabetes in adults, requires consistent use, even with seemingly controlled blood sugar, to mitigate risks such as kidney complications, vision impairment, neuropathy, and limb loss. Discontinuing treatment necessitates prior physician consultation. Successful management relies heavily on a comprehensive approach encompassing this medication, alongside a balanced diet, regular exercise, and weight management as guided by your healthcare provider. Commonly reported is hypoglycemia (low blood sugar), characterized by symptoms such as tremors, sweating, dizziness, and headaches. Regular meals, along with readily available glucose sources (e.g., sugary snacks or juice), are crucial for prevention. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include gastrointestinal distress (nausea, diarrhea, stomach pain), altered taste perception, headaches, upper respiratory infections, and weight gain. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before initiating treatment. Pregnant or lactating individuals require medical consultation before using this medication. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are essential components of treatment.

Uses of Glimecheck M 0.5 Tablet SR

Managing type 2 diabetes

Major Benefits of Glimecheck M 0.5 Tablet SR:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimecheck M 0.5 Tablet SR with a meal.

Common Side effects of Glimecheck M 0.5 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimecheck M 0.5 Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimecheck M 0.5 Tablet SR with a meal.

How Glimecheck M 0.5 Tablet SR works:

Glimecheck M 0.5 SR tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness in the body.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Glimecheck M 0.5 Tablet SR is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glimecheck M 0.5mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimecheck M 0.5 mg tablets are contraindicated during lactation. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimecheck M 0.5 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician for guidance. Glimecheck M 0.5 Tablet SR is contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimecheck M 0.5 mg sustained-release tablets cautiously, potentially requiring dose modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dosage; however, it's contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimecheck M 0.5 Tablet SR :

Should you forget a Glimecheck M 0.5 Tablet SR dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glimecheck M 0.5 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimecheck M 0.5 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimecheck M 0.5 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimecheck M 0.5 Tablet SR and seek immediate medical attention.
Glimecheck M 0.5 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. It's not suitable for type 1 DM.
Glimepiride 0.5mg SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach ache, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glimepiride (Glimecheck M 0.5 Tablet SR) use can lead to Vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
Glimepiride (Glimecheck M 0.5 Tablet SR) can lower blood sugar levels, potentially causing hypoglycemia. Hypoglycemia symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases if meals are skipped or delayed, alcohol is consumed, excessive exercise occurs, or other diabetes medications are used concurrently. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimecheck M 0.5 Tablet SR with alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimecheck M 0.5 Tablet S...
48
MRP 58
17% off